675. Sulbactam-durlobactam (SUL-DUR) versus colistin therapy in patients with Acinetobacter baumannii-calcoaceticus complex (ABC) infections: A detailed safety review from the pivotal phase 3, global, randomized, active-controlled trial (ATTACK)

作者
Drew E. Lewis,Khurram Z. Rana,Gabrielle Poirier,David Altarac
出处
期刊:Open Forum Infectious Diseases [Oxford University Press]
卷期号:9 (Supplement_2) 被引量:1
标识
DOI:10.1093/ofid/ofac492.727
摘要

Abstract Background SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC, which is a cause of severe infections with substantial mortality. ATTACK evaluated the efficacy and safety of SUL-DUR versus colistin (COL) in patients with serious ABC infections. The primary efficacy endpoint, 28-day all-cause mortality, was achieved. The safety profile of SUL-DUR versus colistin is presented here. Methods ATTACK consisted of two parts. Part A was the randomized, non-inferiority portion in ABC hospital-acquired bacterial pneumonia, ventilator-associated bacterial pneumonia, ventilated pneumonia, or bacteremia; patients were randomized 1:1 to SUL-DUR or colistin for 7 to 14 days. Part B provided open label SUL-DUR for patients intolerant of colistin or with colistin-resistant ABC. Safety data presented here include both Part A and Part B. All patients received imipenem/cilastatin as background therapy. The primary safety objective was nephrotoxicity (RIFLE classification); other safety endpoints included treatment-emergent adverse events (TEAEs) and assessments of laboratory parameters. Results The safety population includes 203 unique patients. TEAEs were common reflecting the critical level of illness. More frequently reported with colistin treatment are severe, serious, and drug-related TEAEs (infections, renal and urinary disorders, and gastrointestinal) (Table 1). Nervous system, infections and renal disorders leading to discontinuation of study drug were more common in the colistin arm (Table 2). During treatment, liver-associated enzymes were similar between arms. Creatinine clearance measures of central tendency showed reduction during the trial in the colistin arm. Nephrotoxicity (RIFLE classification) occurred significantly less often with SUL-DUR: 13.2% (12/91) and 37.6% (32/85), difference -24.4% [p=0.0002]. Conclusion SUL-DUR treated patients had reduced nephrotoxicity, fewer drug-related TEAEs, no safety signals, and fewer TEAEs leading to discontinuation of study drug. If approved, SUL-DUR could be an important therapeutic option for Acinetobacter infections including carbapenem-resistant and multidrug-resistant strains. Disclosures Drew Lewis, MD, MTM&H, Entasis Therapeutics: employee|Entasis Therapeutics: employee|Entasis Therapeutics: Stocks/Bonds|Entasis Therapeutics: Stocks/Bonds Khurram Rana, PharmD, Entasis Therapeutics: Employee|Entasis Therapeutics: Ownership Interest|Entasis Therapeutics: Stocks/Bonds Gabrielle Poirier, BS, Entasis Therapeutics: Ownership Interest|Entasis Therapeutics: Stocks/Bonds David Altarac, MD, MPA, Entasis Therapeutics: Ownership Interest|Entasis Therapeutics: Stocks/Bonds.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
W1ndyKnight发布了新的文献求助10
刚刚
失落完成签到 ,获得积分20
刚刚
坚定的夜南完成签到,获得积分10
1秒前
1秒前
1秒前
Reina发布了新的文献求助10
1秒前
2秒前
91hkw完成签到,获得积分10
3秒前
荼蘼发布了新的文献求助10
3秒前
nenenn发布了新的文献求助10
5秒前
蓬莱第几宫完成签到,获得积分10
5秒前
小小小乐完成签到 ,获得积分10
6秒前
6秒前
罗小黑发布了新的文献求助10
6秒前
Owen的应助被谢伊代采纳,获得10
6秒前
dzy完成签到,获得积分10
8秒前
9秒前
Akim的应助被老年学术废物采纳,获得10
9秒前
10秒前
10秒前
Heloise完成签到,获得积分10
10秒前
卡夫卡的熊完成签到 ,获得积分10
11秒前
Capricorn完成签到 ,获得积分10
11秒前
水牛完成签到,获得积分10
12秒前
橡木wll完成签到,获得积分10
12秒前
Orange的应助被舒心的乌龟采纳,获得10
13秒前
斯多姆发布了新的文献求助10
13秒前
隐形曼青的应助被张兆阳采纳,获得10
14秒前
zzy完成签到 ,获得积分10
14秒前
小汪快跑完成签到 ,获得积分10
15秒前
爆米花的应助被mkbk采纳,获得10
15秒前
荼蘼发布了新的文献求助10
15秒前
地雷完成签到 ,获得积分10
17秒前
高贵飞丹发布了新的文献求助10
17秒前
梅溪湖的提词器完成签到,获得积分0
17秒前
成就盼易发布了新的文献求助10
17秒前
18秒前
18秒前
开朗鱼丸完成签到,获得积分10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175157
求助须知:如何正确求助?哪些是违规求助? 9566955
关于积分的说明 21789278
捐赠科研通 7769593
什么是DOI,文献DOI怎么找? 3431836
关于科研通互助平台的介绍 2556078
邀请新用户注册赠送积分活动 2477241